HBV Research Protocols

Fluorescent-bait labelling for the ex vivo detection of HBV antigen-specific B cells

SENIOR AUTHOR
MAIN AUTHOR

Author's Information

Nina Le Bert (1), Loghman Salimzadeh (1), Alice R. Burton (2), Mala K. Maini (2) Antonio Bertoletti (1)

(1) Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore (2) Division of Infection and Immunity, UCL, London, UK

Introduction

Fluorescently conjugated antigen-bait systems have been extensively used to identify antigen-specific B cells and probe humoral immunity across different settings. Using this principle, HBV antigens are used to bind the B cell receptor (BCR), permitting antigen-specific B cell detection by flow cytometry1,2. Fluorochromes can either be attached covalently via chemical conjugation to the antigen or attached non-covalently by biotinylating the antigen. Dual-staining antigen-baits (where an antigen is directly conjugated to two distinct fluorochromes) have now been used to identify HBsAg- and HBcAg-specific B cells with a high degree of reliability and specificity3. This system can be used to detect and characterise cells ex vivo or adapted to isolate antigen-specific cells using fluorescence-activated cell sorting.

Materials and Reagents

  • HBV antigen baits:
    • HBcAg-Dy550 and HBcAg-Dy650
    • HBsAg-Dy550 and HBsAg-Dy650
NB:// Antigen baits not commercially available but gained via courtesy of Gilead Sciences Inc.
  • Fixable Live/Dead™ stain (Invitrogen™)
  • FcR blocking reagent (Miltenyi Biotec)
  • Brilliant Stain buffer (BD Biosciences™)
  • BD Cytofix™ (BD Biosciences™)
  • 96-well U-bottomed plates OR 5ml polypropylene tubes

Experimental Procedures

Prepare 1 x 106 – 3 x 106 PMBCs, from freshly isolated PBMCs or thawed from frozen, per stain. All staining should be performed on a single-cell suspension either in 96-well U-bottomed plates or in 5ml polypropylene tubes.
  1. Centrifuge cells (300g, 4 min at 4ºC)
  2. Stain cell pellet with a fixable cell viability dye diluted in PBS (Live/Dead™ stain, Invitrogen™) for 15 min at 4ºC
  3. Wash cells using 1x PBS and centrifugation (300g, 4 min at 4ºC)
  4. Block non-specific antibody binding using FcR blocking reagent (Miltenyi Biotec) for 15 min at 4ºC
  5. Stain cells with 50ml of anti-human monoclonal antibodies of interest, in combination with Dy550 and Dy650 antigen baits at the following concentrations:
HBsAg -Dy550 and -Dy650: 10-20ug/ml HBcAg -Dy550 and -Dy650: 300-600ng/ml Dilute antibodies in 50%-Brilliant Stain buffer (BD Biosciences™) and 50%-PBS supplemented with 0.5%-FBS and 2mM EDTA to minimize interactions between multiple fluorescent dyes. Incubate cells with monoclonal antibodies and antigen-baits for 30 min in the dark on ice.
  1. Wash cells with PBS supplemented with 0.5%-FBS and 2mM EDTA and centrifugation (300g, 4 min at 4ºC)
  2. Fix cells (BD Cytofix™, BD Biosciences™) prior to acquisition
TIP: Run the cells at a low threshold rate and make sure to acquire all of the cells Stringent gating criteria should be applied during analysis to exclude doublet, dead and CD19-negative cells. Cells stained with an identical panel minus antigen-bait staining can be used to control for non-specific binding and guide gating. All reagents used should be stored at 4ºC; monoclonal antibodies and antigen-baits should be stored in the dark.

References

  1. Salimzadeh, L. et al. PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J. Clin. Invest. (2018) doi:10.1172/JCI121957.
  2. Burton, A. R. et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest 128, 4588–4603 (2018). DOI: 10.1172/JCI121960
  3. Bert, N. L. et al. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B. Journal of Hepatology 72, 34–44 (2020). DOI: 10.1016/j.jhep.2019.07.015

Recently Published Protocols